Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
470.1 USD | -0.51% |
|
+0.39% | +15.65% |
01:00pm | Verve Therapeutics, Inc. Announces Board Appointments | CI |
06-27 | Redburn Atlantic Initiates Vertex Pharmaceuticals at Buy With $545 Price Target | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.65% | 122B | |
+19.32% | 113B | |
+18.95% | 26.49B | |
-24.17% | 19.4B | |
-19.03% | 16.24B | |
-21.15% | 15.4B | |
-46.14% | 15.15B | |
+63.81% | 14.93B | |
+4.08% | 13.52B | |
+111.69% | 10.79B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $500 From $456, Maintains Overweight Rating